Are Standard Debridement Practices Maximizing Removal of Bioburden?
(December 7th, 2017)

Figure 4 - FL image

The current gold standard for tissue management in diabetic foot ulcers is regular sharp debridement to reduce bioburden.1 However, a recent study by Rose Raizman, RN-EC MSc, a wound care clinician, which used bacterial fluorescence imaging with the MolecuLight i:X after initial, aggressive debridement in 20 diabetic foot ulcer wound assessments, found that persistent bacterial […]

Read More

Predicting the Presence of Pathogenic Bacteria in Wounds


Why wouldn’t you want to be 100% certain about bacterial presence? In the recent publication in the Journal of Wound Care ‘Point-of-care fluorescence imaging predicts the presence of pathogenic bacteria in wounds: a clinical study1, the authors demonstrated that red fluorescence observed on MolecuLight i:X images of 60 wounds predicted the presence of bacteria 100% […]

Read More

Fish Skin for Human Wounds: Iceland’s Pioneering Treatment (July 26, 2017)


This story was featured in Bloomberg Businessweek. Kerecis Ltd, a small company in Iceland has the only FDA-approved skin substitute derived from fish. Fertram Sigurjonsson is the Chairman and CEO of Kerecis.  His small company has spent the past nine years applying fish skin to the treatment of chronic wounds, those that take longer than […]

Read More